Search Results - "Smeitink, J."

Refine Results
  1. 1
  2. 2

    Mitochondrial disease criteria : Diagnostic applications in children by MORAVA, E, VAN DEN HEUVEL, L, HOL, F, DE VRIES, M. C, HOGEVEEN, M, RODENBURG, R. J, SMEITINK, J. A. M

    Published in Neurology (28-11-2006)
    “…Based on a previous prospective clinical and biochemical study, a consensus mitochondrial disease scoring system was established to facilitate the diagnosis in…”
    Get full text
    Journal Article
  3. 3

    Mechanism of action and potential applications of selective inhibition of microsomal prostaglandin E synthase-1-mediated PGE2 biosynthesis by sonlicromanol’s metabolite KH176m by Jiang, X., Renkema, H., Pennings, B., Pecheritsyna, S., Schoeman, J. C., Hankemeier, T., Smeitink, J., Beyrath, J.

    Published in Scientific reports (13-01-2021)
    “…Increased prostaglandin E2 (PGE 2 ) levels were detected in mitochondrial disease patient cells harboring nuclear gene mutations in structural subunits of…”
    Get full text
    Journal Article
  4. 4

    Mitochondrial medicine: entering the era of treatment by Koene, S., Smeitink, J.

    Published in Journal of internal medicine (01-02-2009)
    “… Research of patients with defects in cellular energy metabolism (mitochondrial disease) has led to a better understanding of mitochondrial biology in health…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction by Ahlqvist, K.J., Leoncini, S., Pecorelli, A., Wortmann, S.B., Ahola, S., Forsström, S., Guerranti, R., De Felice, C., Smeitink, J., Ciccoli, L., Hämäläinen, R.H., Suomalainen, A.

    Published in Nature communications (09-03-2015)
    “…Haematopoietic progenitor cells show special sensitivity to mitochondrial DNA (mtDNA) mutagenesis, which suggests that increased mtDNA mutagenesis could…”
    Get full text
    Journal Article
  6. 6

    The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases by Breuer, M.E, Koopman, W.J, Koene, S, Nooteboom, M, Rodenburg, R.J, Willems, P.H, Smeitink, J.A.M

    Published in Neurobiology of disease (01-03-2013)
    “…Abstract The development of neurologic disease is a complex and multi-faceted process. Several factors, such as physiology, environment and genetics may play…”
    Get full text
    Journal Article
  7. 7

    Mining for mitochondrial mechanisms: Linking known syndromes to mitochondrial function by Panneman, D.M., Smeitink, J.A., Rodenburg, R.J.

    Published in Clinical genetics (01-05-2018)
    “…Mitochondrial disorders (MDs) are caused by defects in 1 or multiple complexes of the oxidative phosphorylation (OXPHOS) machinery. MDs are associated with a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect by Baertling, F., Sánchez‐Caballero, L., van den Brand, M.A.M., Fung, C.‐W., Chan, S.H.‐S., Wong, V.C.‐N., Hellebrekers, D.M.E., de Coo, I.F.M., Smeitink, J.A.M., Rodenburg, R.J.T., Nijtmans, L.G.J.

    Published in Clinical genetics (01-01-2018)
    “…Mitochondrial respiratory chain complex I consists of 44 different subunits and contains 3 functional modules: the Q‐, the N‐ and the P‐module. NDUFA9 is a…”
    Get full text
    Journal Article
  10. 10

    Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy by Brinkman, Kees, Smeitink, Jan A, Romijn, Johannes A, Reiss, Peter

    Published in The Lancet (British edition) (25-09-1999)
    “…Highly active antiretroviral therapy (HAART) can induce a characteristic lipodystrophy syndrome of peripheral fat wasting and central adiposity. HIV-1 protease…”
    Get full text
    Journal Article
  11. 11

    Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? — a retrospective pilot study by Koene, S., Timmermans, J., Weijers, G., de Laat, P., de Korte, C. L., Smeitink, J. A. M., Janssen, M. C. H., Kapusta, L.

    Published in Journal of inherited metabolic disease (01-03-2017)
    “…Objectives Cardiomyopathy is a common complication of mitochondrial disorders, associated with increased mortality. Two dimensional speckle tracking…”
    Get full text
    Journal Article
  12. 12

    Major depression in adolescent children consecutively diagnosed with mitochondrial disorder by Koene, S, Kozicz, T.L, Rodenburg, R.J.T, Verhaak, C.M, de Vries, M.C, Wortmann, S, van de Heuvel, L, Smeitink, J.A.M, Morava, E

    Published in Journal of affective disorders (01-04-2009)
    “…Abstract A higher incidence of major depression has been described in adults with a primary oxidative phosphorylation disease. Intriguingly however, not all…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Dysphagia, malnutrition and gastrointestinal problems in patients with mitochondrial disease caused by the m3243A>G mutation by de Laat, P, Zweers, H E E, Knuijt, S, Smeitink, J A M, Wanten, G J A, Janssen, M C H

    Published in Netherlands journal of medicine (01-01-2015)
    “…Previous research has shown that dysphagia and gastrointestinal problems occur frequently in carriers of the m.3243A>G mutation; however, the exact frequency…”
    Get full text
    Journal Article
  15. 15

    Adverse effects of reverse transcriptase inhibitors : mitochondrial toxicity as common pathway by BRINKMAN, K, TER HOFSTEDE, H. J. M, BURGER, D. M, SMEITINK, J. A. M, KOOPMANS, P. P

    Published in AIDS (London) (01-10-1998)
    “…After zidovudine (ZDV), a 3'-azido analogue of thymidine, was found to be an effective antiretroviral drug against HIV, other nucleoside analogues inhibiting…”
    Get full text
    Journal Article
  16. 16

    Transcriptional changes in OXPHOS complex I deficiency are related to anti-oxidant pathways and could explain the disturbed calcium homeostasis by Voets, A.M., Huigsloot, M., Lindsey, P.J., Leenders, A.M., Koopman, W.J.H., Willems, P.H.G.M., Rodenburg, R.J., Smeitink, J.A.M., Smeets, H.J.M.

    Published in Biochimica et biophysica acta (01-07-2012)
    “…Defective complex I (CI) is the most common type of oxidative phosphorylation disease, with an incidence of 1 in 5000 live births. Here, whole genome…”
    Get full text
    Journal Article
  17. 17

    ‘Splitting versus lumping’: Temple–Baraitser and Zimmermann–Laband Syndromes by Bramswig, Nuria C., Ockeloen, C. W., Czeschik, J. C., van Essen, A. J., Pfundt, R., Smeitink, J., Poll-The, B. T., Engels, H., Strom, T. M., Wieczorek, D., Kleefstra, T., Lüdecke, H.-J.

    Published in Human genetics (01-10-2015)
    “…KCNH1 mutations have recently been described in six individuals with Temple–Baraitser syndrome (TMBTS) and six individuals with Zimmermann–Laband syndrome…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Sequence variants in four candidate genes (NIPSNAP1, GBAS, CHCHD1 and METT11D1) in patients with combined oxidative phosphorylation system deficiencies by Smits, P., Rodenburg, R. J., Smeitink, J. A. M., van den Heuvel, L. P.

    Published in Journal of inherited metabolic disease (01-12-2010)
    “…Summary The oxidative phosphorylation (OXPHOS) system, comprising five enzyme complexes, is located in the inner membrane of mitochondria and is the final…”
    Get full text
    Journal Article
  20. 20

    A Second Common Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects? by van der Put, Nathalie M.J., Gabreëls, Fons, Stevens, Erik M.B., Smeitink, Jan A.M., Trijbels, Frans J.M., Eskes, Tom K.A.B., van den Heuvel, Lambert P., Blom, Henk J.

    Published in American journal of human genetics (01-05-1998)
    “…Recently, we showed that homozygosity for the common 677(C→T) mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, causing thermolability of the…”
    Get full text
    Journal Article